Dudediligence.

Foghorn Therapeutics Inc

FHTXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Exit or restructuring costsOct 1 →InsidersNo open-market buys or sales.→HoldersFlagship Pioneering 21.6%BVF Inc/il 9.9%FMR 9.7%→Financing →PeersClosest companies: CCCC, NRIX, TNGX→

From the filings

Figures

Revenue
$36.7Mlast 12 months
Net income
−$64.6Mlast 12 months
Operating cash flow
−$87.4Mlast 12 months
Cash and equivalents
$68.1Mat the last balance sheet
Shares outstanding
58.7M shareson issue
Every year and quarter →